• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体素内不相干运动(IVIM)得出的无模型参数在评估鼻咽癌病理指标和长期生存方面的潜力

The Potential of Model-Free Parameters Derived From IVIM in Evaluating Pathological Indicators and Long-Term Survival in NPC.

作者信息

Yang Fan, Wei Haoran, Li Xiaolu, Yu Xiaoduo, Li Lin, Zhao Yanfeng, Xie Lizhi, Jiang Yueluan, Lin Meng, Zhang Hongmei

机构信息

Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Radiology, Division of Neuroimaging and Neurointervention, Stanford University, Stanford University Medical Center, Stanford, California, USA.

出版信息

J Magn Reson Imaging. 2025 Jul;62(1):73-86. doi: 10.1002/jmri.29725. Epub 2025 Mar 10.

DOI:10.1002/jmri.29725
PMID:40062840
Abstract

BACKGROUND

IVIM is a useful quantitative tool for predicting prognosis, but it is labor-intensive. Simplified b-value settings and post-processing could be more practicable for clinical applications.

PURPOSE

To assess the value of model-free parameters (virtual MR elastography [vMRE] and signature-index [S-index]) derived from IVIM in evaluating pathological indicators and long-term survival in nasopharyngeal carcinoma (NPC), and to compare those with model-based parameters.

STUDY TYPE

Prospective.

POPULATION

One hundred six patients (median: 49.5 years, 19.8% females).

FIELD STRENGTH/SEQUENCE: 3-T, IVIM, T1- and T2-weighted imaging, contrast-enhanced T1-weighted imaging.

ASSESSMENT

The volumes of primary tumors were separately delineated. vMRE and S-index were calculated based on two b-values (200 and 1500 s/mm), and correlations with pathological indicators (histology, epidermal growth factor receptor [EGFR] level) were analyzed. Six types of model-based parameters were constructed using all b-values. The value in predicting overall survival (OS) and progression-free survival (PFS) was calculated. The vMRE/S-index-Clinic model and tumor-node-metastasis (TNM) staging model were constructed.

STATISTICAL TEST

Spearman and intraclass correlation analysis (ICC), univariate and multivariate Cox analyses with seven clinical factors. Significance level: P-value < 0.05.

RESULTS

The median follow-up duration was 63.0 (interquartile range: 55.9, 100.3) months. All parameters showed excellent agreement (all ICC ≥ 0.790). The vMRE/S-index was significantly correlated with EGFR level and histology. Moreover, the vMRE/S-index was an independent predictor of PFS (hazard ratio [HR]: 0.639 and 2.365, respectively) and OS (HR: 0.690 and 2.116, respectively). The performance of the vMRE/S-index (C-index: 0.585 ~ 0.631) was comparable to that of the model-based parameters (C-index: 0.551 ~ 0.630). The vMRE-Clinic model (C-index: 0.700 and 0.702 for PFS and OS, respectively) and the S-index-Clinic model (C-index: 0.703 and 0.709 for PFS and OS, respectively) demonstrated superior performance compared to TNM staging model.

CONCLUSION

Model-free parameters from IVIM can predict long-term survival in NPC.

PLAIN LANGUAGE SUMMARY

This study employed two simplified model-free parameters: the virtual MR Elastography (vMRE) to measure tissue stiffness and the signature index (S-index) to reveal the intricate tissues microstructures. These two parameters showed the comparable value in EGFR expression level and histology diagnosis as well as long-term survival prediction in nasopharyngeal carcinoma. Patients with high vMRE and low S-index value have favorable treatment outcome. Taking advantage of shorter MRI scan time and post-processing difficulty, the two model-free parameters showed good prospects in clinical application.

EVIDENCE LEVEL

2 TECHNICAL EFFICACY: Stage 2.

摘要

背景

体素内不相干运动(IVIM)是预测预后的一种有用的定量工具,但它劳动强度大。简化的b值设置和后处理对于临床应用可能更实用。

目的

评估从IVIM得出的无模型参数(虚拟磁共振弹性成像[vMRE]和特征指数[S指数])在评估鼻咽癌(NPC)的病理指标和长期生存中的价值,并将其与基于模型的参数进行比较。

研究类型

前瞻性研究。

研究对象

106例患者(中位数:49.5岁,19.8%为女性)。

场强/序列:3-T,IVIM、T1加权和T2加权成像、对比增强T1加权成像。

评估

分别勾勒出原发肿瘤的体积。基于两个b值(200和1500 s/mm²)计算vMRE和S指数,并分析其与病理指标(组织学、表皮生长因子受体[EGFR]水平)的相关性。使用所有b值构建六种基于模型的参数。计算预测总生存(OS)和无进展生存(PFS)的价值。构建vMRE/S指数-临床模型和肿瘤-淋巴结-转移(TNM)分期模型。

统计检验

Spearman检验和组内相关分析(ICC),对七个临床因素进行单因素和多因素Cox分析。显著性水平:P值<0.05。

结果

中位随访时间为63.0(四分位间距:55.9,100.3)个月。所有参数均显示出极好的一致性(所有ICC≥0.790)。vMRE/S指数与EGFR水平和组织学显著相关。此外,vMRE/S指数分别是PFS(风险比[HR]:0.639和2.365)和OS(HR:0.690和2.116)的独立预测因子。vMRE/S指数(C指数:0.585~0.631)的性能与基于模型的参数(C指数:0.551~0.630)相当。vMRE-临床模型(PFS和OS的C指数分别为0.700和0.702)和S指数-临床模型(PFS和OS的C指数分别为0.703和0.709)与TNM分期模型相比表现出更好的性能。

结论

IVIM的无模型参数可预测NPC的长期生存。

通俗易懂的总结

本研究采用了两个简化的无模型参数:用于测量组织硬度的虚拟磁共振弹性成像(vMRE)和用于揭示复杂组织微观结构的特征指数(S指数)。这两个参数在EGFR表达水平、组织学诊断以及鼻咽癌长期生存预测方面显示出相当的价值。vMRE高和S指数低的患者治疗效果良好。利用较短的MRI扫描时间和后处理难度,这两个无模型参数在临床应用中显示出良好的前景。

证据水平

2 技术效能:2级

相似文献

1
The Potential of Model-Free Parameters Derived From IVIM in Evaluating Pathological Indicators and Long-Term Survival in NPC.基于体素内不相干运动(IVIM)得出的无模型参数在评估鼻咽癌病理指标和长期生存方面的潜力
J Magn Reson Imaging. 2025 Jul;62(1):73-86. doi: 10.1002/jmri.29725. Epub 2025 Mar 10.
2
Model-free parameters derived from intravoxel inherent motion combined with tumor aggressiveness indicators in predicting 5-year treatment outcome in NPC.基于体素内固有运动得出的无模型参数与肿瘤侵袭性指标相结合,用于预测鼻咽癌的5年治疗结果。
Oral Oncol. 2025 Mar;162:107187. doi: 10.1016/j.oraloncology.2025.107187. Epub 2025 Feb 22.
3
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.